Taisho Pharmaceutical R&D Inc. clinical trials

A subsidiary of Taisho Pharmaceutical Co., Ltd.

The registry lists 8 studies whose lead sponsor is Taisho Pharmaceutical R&D Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 10, 2021.

Studies

Recruiting first, then most recently updated. Showing 8 of 8. All Taisho Pharmaceutical Co., Ltd. studies →

• A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy ParticipantsCompletedNCT04464239Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive DisorderTerminatedNCT03093025Phase 2

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy ParticipantsCompletedNCT03919409Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy VolunteersCompletedNCT03746067Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy VolunteersCompletedNCT03742791Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy SubjectsCompletedNCT03141658Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male SubjectsCompletedNCT02448212Phase 1

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.

• Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)CompletedNCT00914186Phase 2

  Sponsor listed in the registry: Taisho Pharmaceutical R&D Inc.